Sotera Health (SHC) EBIT (2020 - 2026)

Sotera Health (SHC) has reported EBIT for 7 consecutive years, with $78.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT rose 8.96% year-over-year to $78.9 million; the TTM figure through Mar 2026 stood at $399.3 million (up 26.02% YoY), while the FY2025 annual figure was $392.8 million, up 31.97% from the prior year.
• EBIT came in at $78.9 million for Q1 2026 at Sotera Health, down from $108.4 million in the prior quarter.
• The five-year high for EBIT was $114.3 million in Q3 2025, with the low at $33.4 million in Q1 2023.
• Average EBIT over 5 years is $76.1 million, with a median of $76.1 million recorded in 2023.
• The largest YoY upside for EBIT was 72.89% in 2023 against a maximum downside of 37.62% in 2023.
• Year by year, EBIT stood at $60.2 million in 2022, then jumped by 72.89% to $104.0 million in 2023, then dropped by 16.23% to $87.1 million in 2024, then climbed by 24.4% to $108.4 million in 2025, then fell by 27.26% to $78.9 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $78.9 million, $108.4 million, and $114.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.